What does Invus invest in?
Invus invests most often at Venture and Series B (55% of the rounds on record), in sectors such as AI & Machine Learning, Artificial Intelligence & Machine Learning (AI/ML) and Asia Private Equity.

United States · Investor
Last cheque observed Oct 2026; 148 cheques on record.
Deploying nowNew fund, Mar 2025Private equity
Follow Invus and see its new cheques in your feed.Start following
26 cheques in the last 12 months
Mostly Venture and Series B: 55% of its rounds
Sole investor in 27 rounds, median $21M
1 exits from the portfolio
Includes investments in private companies where Invus was the only or the lead investor with $10M+ equity, and where the investment has been fully or partially exited since 1993.From their own website
Every round we can evidence, newest first148 appearances
21 rounds
18 rounds
17 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
We also hold 27 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Funds on its Form ADV
23 private funds, $5.8B in gross assets · filed Nov 2024
Private equity 18Hedge 4Private investment vehicle 1
And 13 more on the filing.
Companies it backed that were later bought or listed1 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Invus. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Invus put money into.
Invus invests most often at Venture and Series B (55% of the rounds on record), in sectors such as AI & Machine Learning, Artificial Intelligence & Machine Learning (AI/ML) and Asia Private Equity.
148 investments on record, 26 of them in the last 12 months, and it led 4. The most recent was in Oct 2026.
Its most recent investments on record: Matchpoint Therapeutics (Series B, Oct 2026), EliseAI (Growth, Sept 2026) and Precision Neuroscience (Growth, Sept 2026).
The median round it joins is $81M.
Sometimes: it led 4 of its 148 investments on record (3%).
Most of the companies it backs are in the United States (78%) and France (11%).
Yes: it is actively investing, with 26 investments in the last 12 months.
Most often RA Capital Management (15 rounds together), Fidelity (11 rounds together) and Janus Henderson Investors (10 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it